Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

SHA:603896 Revenue

Zhejiang Shouxiangu Pharmaceutical had revenue of 161.03M CNY in the quarter ending March 31, 2026, a decrease of -5.72%. This brings the company's revenue in the last twelve months to 625.30M, down -5.27% year-over-year. In the year 2025, Zhejiang Shouxiangu Pharmaceutical had annual revenue of 640.18M, down -9.21%.

• Revenue (ttm): 625.30M
• Revenue Growth: -5.27%
• P/S Ratio: 5.45
• Revenue / Employee: 558.80K
• Employees: 1,119
• Market Cap: 3.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	640.18M	-64.93M	-9.21%
Dec 31, 2024	705.11M	-79.24M	-10.10%
Dec 31, 2023	784.35M	-44.72M	-5.39%
Dec 31, 2022	829.07M	61.93M	8.07%
Dec 31, 2021	767.14M	131.09M	20.61%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error